| 000 | 01841 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516030834.0 | ||
| 264 | 0 | _c20140728 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1878-0938 | ||
| 024 | 7 |
_a10.1016/j.carrev.2010.02.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOkabe, Teruo | |
| 245 | 0 | 0 |
_aCan intravascular ultrasound guidance modify the efficacy of drug-eluting stent over bare-metal stent in an aorto-ostial lesion? _h[electronic resource] |
| 260 |
_bCardiovascular revascularization medicine : including molecular interventions _c |
||
| 300 |
_a105-10 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiovascular Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCoronary Artery Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetals |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xadverse effects |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aProsthesis Design |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSirolimus _xadministration & dosage |
| 650 | 0 | 4 | _aStents |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUltrasonography, Interventional |
| 700 | 1 | _aKawamura, Akio | |
| 700 | 1 | _aMaekawa, Yuichiro | |
| 700 | 1 | _aAnzai, Toshihisa | |
| 700 | 1 | _aIwanaga, Shiro | |
| 700 | 1 | _aYoshikawa, Tsutomu | |
| 700 | 1 | _aOgawa, Satoshi | |
| 773 | 0 |
_tCardiovascular revascularization medicine : including molecular interventions _gvol. 12 _gno. 2 _gp. 105-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.carrev.2010.02.002 _zAvailable from publisher's website |
| 999 |
_c20691611 _d20691611 |
||